Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion

被引:158
作者
Atay, Safinur [1 ]
Banskota, Samagya [1 ]
Crow, Jennifer [1 ]
Sethi, Geetika [1 ,2 ]
Rink, Lori [3 ]
Godwin, Andrew K. [1 ,4 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA
[2] Drexel Univ, Coll Med, Dept Biochem, Philadelphia, PA 19104 USA
[3] Fox Chase Canc Ctr, Dev Therapeut Program, Philadelphia, PA 19111 USA
[4] Univ Kansas, Ctr Canc, Kansas City, KS 66160 USA
关键词
ICC; crosstalk; microvesicles; tumor microenvironment; PERSONALIZED THERAPY; INTERSTITIAL-CELLS; CANCER-THERAPY; C-KIT; GIST; EXPRESSION; INHIBITORS; CARCINOMA; MMP-1; PROGRESSION;
D O I
10.1073/pnas.1310501111
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
During tumor development, constant interplay occurs between tumor cells and surrounding stromal cells. We report evidence that gastrointestinal stromal tumor (GIST) cells invade the interstitial stroma through the release of the oncogenic protein tyrosine kinase (KIT)-containing exosomes, which triggers the phenotypic conversion of progenitor smooth muscle cells to tumor-promoting cells. These recipient cells display morphologic changes and acquire tumor-associated phenotypes, including enhanced adhesion to extracellular matrix proteins, activation of intracellular pathways downstream of KIT, expression of Interstitial Cell of Cajal-like markers, and release of various matrix metalloproteinases (MMPs), particularly MMP1. This report shows stimulation of MMP1 production by stromal cells via uptake of tumor-derived exosomes, which leads to tumor cell invasion. Exosomes derived from GIST patients but not healthy donors show enhanced MMP1 secretion by smooth muscle cells and tumor cell invasion, whereas selective blocking of exosome-mediated MMP1 secretion decreases tumor invasiveness. Our study indicates that exosome release and subsequent MMP1 induction creates a positive feedback mechanism established between tumor and stromal cells that drives GIST development and offers unique insights for potential therapeutic strategies to block GIST progression and metastatic spread.
引用
收藏
页码:711 / 716
页数:6
相关论文
共 35 条
[1]
Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer [J].
Agarwal, Anika ;
Covic, Lidija ;
Sevigny, Leila M. ;
Kaneider, Nicole C. ;
Lazarides, Katherine ;
Azabdaftari, Gissou ;
Sharifi, Sheida ;
Kuliopulos, Athan .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) :2746-2757
[2]
Malignant effusions and immunogenic tumour-derived exosomes [J].
Andre, F ;
Schartz, NEC ;
Movassagh, M ;
Flament, C ;
Pautier, P ;
Morice, P ;
Pomel, C ;
Lhomme, C ;
Escudier, B ;
Le Chevalier, T ;
Tursz, T ;
Amigorena, S ;
Raposo, G ;
Angevin, E ;
Zitvogel, L .
LANCET, 2002, 360 (9329) :295-305
[3]
Human Trophoblast-Derived Exosomal Fibronectin Induces Pro-Inflammatory Il-1β Production by Macrophages [J].
Atay, Safinur ;
Gercel-Taylor, Cicek ;
Taylor, Douglas D. .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 (04) :259-269
[4]
Trophoblast-Derived Exosomes Mediate Monocyte Recruitment and Differentiation [J].
Atay, Safinur ;
Gercel-Taylor, Cicek ;
Suttles, Jill ;
Mor, Gil ;
Taylor, Douglas D. .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 65 (01) :65-77
[5]
Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications [J].
Basset, P ;
Okada, A ;
Chenard, MP ;
Kannan, R ;
Stoll, I ;
Anglard, P ;
Bellocq, JP ;
Rio, MC .
MATRIX BIOLOGY, 1997, 15 (8-9) :535-541
[6]
Blay JY, 2012, DISCOV MED, V13, P357
[7]
Exosomal-like vesicles are present in human blood plasma [J].
Caby, MP ;
Lankar, D ;
Vincendeau-Scherrer, C ;
Raposo, G ;
Bonnerot, C .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (07) :879-887
[8]
Chaput N, 2003, ADV EXP MED BIOL, V532, P215
[9]
Shedding microvesicles: artefacts no more [J].
Cocucci, Emanuele ;
Racchetti, Gabriella ;
Meldolesi, Jacopo .
TRENDS IN CELL BIOLOGY, 2009, 19 (02) :43-51
[10]
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392